NCT00019812View on ClinicalTrials.gov

Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

February 29, 2004

Conditions

Breast Cancer

Interventions

BIOLOGICAL

trastuzumab

DRUG

paclitaxel

Trial Locations (3)

33308

Holy Cross Hospital, Fort Lauderdale

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

26506-9162

Mary Babb Randolph Center, Morgantown

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00019812 - Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2 | Biotech Hunter | Biotech Hunter